Ligand (LGNZZ) Form 144 Filed for 10,000 Common Shares Sale

Rhea-AI Filing Summary

Form 144 notice for proposed sale of 10,000 common shares by an insider through Morgan Stanley Smith Barney LLC. The filing states the aggregate market value of the shares to be sold is $1,708,087.44 based on 10,000 shares, with approximately 19,596,560 shares outstanding for the issuer. The approximate date of sale is listed as 09/23/2025. The filer reports no securities sold in the past three months. Acquisition details show the 10,000 shares were acquired in multiple lots between 06/04/2022 and 06/06/2025 via restricted stock grants and exercised share transactions, with specific lot sizes and payment methods noted where applicable.

Positive

• Broker identified as Morgan Stanley Smith Barney LLC, enabling orderly execution
• Full acquisition history disclosed with dates and lot sizes, including restricted stock and exercised shares

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Insider intends to sell 10,000 shares via a registered broker on 09/23/2025; acquisition history is disclosed.

The filing meets Rule 144 disclosure requirements by identifying the broker, number of shares, aggregate market value, and the approximate sale date. The table of acquisitions lists multiple restricted stock grants and exercised-share lots with dates and payment types, which supports the filer’s ability to sell under Rule 144 resale conditions. The absence of reported sales in the prior three months is explicitly stated. From a compliance perspective, the form appears complete for a proposed transaction notice.

Equity Transactions Specialist

TL;DR: Transaction is routine documentation of an insider sale; details on lot dates and payment types are included.

The filing provides specific lot-level acquisition information: restricted stock grants on 06/04/2022, 06/09/2023, 06/09/2024, 06/06/2025 and exercised shares on 03/05/2024 and 04/30/2024, with cash payment noted for exercised lots. A registered broker is named for execution. There are no disclosures of recent sales, litigation, or other qualifiers within this notice that would alter basic market impact assessment. The filing is informational and procedural.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	1708087.44	19596560	09/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/09/2024	Restricted Stock	Issuer			1142	06/09/2024	Not Applicable
Common	03/05/2024	Exercised Shares	Issuer			2893	03/05/2024	Cash
Common	06/04/2022	Restricted Stock	Issuer			630	06/04/2022	Not Applicable
Common	06/09/2023	Restricted Stock	Issuer			1723	06/09/2023	Not Applicable
Common	04/30/2024	Exercised Shares	Issuer			2360	04/30/2024	Cash
Common	06/06/2025	Restricted Stock	Issuer			1252	06/06/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for LGNZZ disclose about the proposed sale?

The form discloses a proposed sale of 10,000 common shares with an aggregate market value of $1,708,087.44, executed through Morgan Stanley Smith Barney LLC on approximately 09/23/2025.

How many shares outstanding does the filing report for the issuer?

The filing reports 19,596,560 shares outstanding for the issuer.

Were any shares sold in the past three months according to the Form 144?

The filing states Nothing to Report for securities sold during the past three months.

What types of acquisitions are listed for the shares being sold?

Acquisitions include multiple restricted stock grants (06/04/2022; 06/09/2023; 06/09/2024; 06/06/2025) and exercised share transactions (03/05/2024; 04/30/2024), with exercised lots paid in cash where noted.

Who is the named broker for the proposed sale on Form 144?

The named broker is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.